Shawn Cross Cyclo Therapeutics, Inc. (CYTH) insider trading activity
Shawn Cross is Director of Cyclo Therapeutics, Inc.. Currently has a direct ownership of 90,521 shares of CYTH, which is worth approximately $57,933. The most recent transaction as insider was on Aug 16, 2024, when has been sold 9,028 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
90.5K
11.08%
3M change
n/a
12M change
Total Value Held
$57,933
Shawn Cross Transaction History
Also insider at
SC
Shawn Cross
Director
South San Francisco, CA